Harbour BioMed, a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics for immunology and oncology, announced an update and advancement of its global strategic collaboration with AstraZeneca, originally established in March 2025. The collaboration aims to discover …
AAVantgarde closing a Series B financing round, AGC Biologics announced a new manufacturing agreement with the biotechnology company, marking AGC Biologics’ latest advancement in the adeno-associated virus market. Under this agreement, AGC Biologics will provide Good Manufacturing Practice manufacturing for AAVantgard…
Nona Biosciences, a global biotechnology company providing integrated solutions for biological drug discovery and development from I to I announced a non-exclusive license agreement with Pfizer designed to accelerate preclinical antibody discovery across a range of potential disease indications. Under the terms of th…
Ginkgo Bioworks announced its partnership with the Institute for Genomic Biology at the University of Illinois Urbana-Champaign on a five-year initiative funded by the Advanced Research Projects Agency for Health (ARPA-H). The collaboration, Microbe/phage Investigation for Generalized Health TherapY (MIGHTY), aims to …
Freenome, an early cancer detection company developing blood-based screening tests, announced a strategic collaboration agreement with Roche to commercialize Freenome's cancer screening technology in international markets. In addition, Freenome will evaluate Roche's forthcoming Sequencing by Expansion (SBX) technology…
Zymo Research, a global leader in next-generation sequencing (NGS), has entered a strategic partnership with biomodal, an omics-based life sciences technology and analytics company. As part of biomodal's certified provider network, Zymo Research's NGS Services division is now authorized to deliver services using biomo…
Lunit, a leading provider of AI for cancer diagnostics and precision oncology, and Labcorp, a global leader of innovative and comprehensive laboratory services, announced a collaborative initiative to accelerate innovation in digital pathology (DP) and artificial intelligence (AI) for oncology research and clinical ca…
Merck, known as MSD outside of the United States and Canada, and Cidara Therapeutics, Inc. a biotechnology company developing drug-Fc conjugate (DFC) therapeutics, today announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Cidara for $221.50 per sh…
SanegeneBio, a clinical-stage biotechnology company developing innovative RNAi therapeutics, announced a global research and licensing collaboration with Eli Lilly and Company . The companies will collaborate to advance RNAi candidates for metabolic diseases, based on SanegeneBio's proprietary tissue selective deliver…
Brenntag, the global market leader in chemicals and ingredients distribution, announced a new and exclusive distribution agreement with ArcticZymes AS on the salt-active nucleases: SAN HQ, SAN-HQ GMP, M-SAN HQ, M-SAN HQ GMP, developed for the efficient removal of nucleic acids in gene therapy, vaccine production and o…
Page 26 of 40